Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Wenyang Lishui Prescription, also known as Wenyang Lishui Decoction (WYD), is a Traditional Chinese Medicine (TCM) herbal formula composed of six key ingredients: Zhi Fu Zi (Aconiti Lateralis Radix Praeparata), Huang Qi (Astragalus membranaceus), Fu Ling (Poria), Bai Zhu (Rhizoma Atractylodis Macrocephalae), Bai Shao (Paeoniae Radix Alba), and Sheng Jiang (Zingiberis Rhizoma Recens). It is being investigated for various therapeutic applications, including its effect on drainage volume and upper limb function in breast cancer patients after operation, as well as for membranous nephropathy and chronic heart failure with diuretic resistance.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Wenyang Lishui Prescription.